The clinical features and molecular biology data of a case of afibrinogenemia are reported. The propositus is a 14-year-old girl who suffered several bleeding manifestations that were successfully treated with fibrinogen infusion. The afibrinogenemia results from compound heterozygosity for two mutations on the Aalpha chain gene (c.[4110delA]+[3200+1G>T]). The first mutation is a novel frameshift mutation inherited from her father. The second is a previously described Aalpha chain gene splice junction mutation inherited from her mother. Neither of the parents fulfills the criteria for hypofibrinogenemia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MBC.0b013e328010bd16 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!